Targeted cancer treatment: Cause of skin infections identified

Targeted cancer treatment: Cause of skin infections identified

Targeted, successful cancer treatments are very often accompanied by unpleasant side effects. Especially in anti-EGFR treatments the skin is often so badly affected by inflammations that patients consider breaking off the highly effective treatment. Researchers at the Comprehensive Cancer Center Vienna (CCC), an establishment belonging to the MedUni Vienna and the Vienna General Hospital, have now managed to break down the mechanisms significantly involved in the uncontrolled inflammatory process.

The growth of cells is triggered by messengers that dock with special proteins on the surface of the cells, so-called EGF receptors (Epidermal Growth Factor Receptor: EGFR). There are increased numbers of receptors on the surface of nearly all and they lead to .

In targeted treatment the EGFRs are switched off, thus hindering the tumour's growth. EGFRs do however control many processes in the skin and therefore play an important role in maintaining a healthy balance in this organ. If the receptors are in short supply then so are the messengers as well and acne-like rashes are the consequence. These are often so distressing to the sufferers that breaking off the treatment necessarily becomes a serious consideration.

Inflammatory mechanism broken down

A team of researchers around Maria Sibilia, the head of the Institute for Cancer Research at the MedUni Vienna and member of the CCC, has now been able to prove in an in vivo study that, once the EGFRs are switched off, inflammatory messengers such as CCL2 and CCL5 appear in increased numbers whilst important and in the skin's epidermis are produced in reduced numbers.

This causes damage to the skin barrier such that pathogens can penetrate more easily and thus contribute to increased . The results show that macrophages and play a significant role in the uncontrolled inflammatory reactions. Says Sibilia: "We were very surprised to find that T- and B-cells, which are such a significant component of the immune defence and thus are always at hand in the combating of pathogens, do not play a significant part in the combating of this ."

Also taking part in this study was a team under Bernhard Homey, Director of the Düsseldorf University Skin Clinic. It was also able to demonstrate the same results in clinical investigations on human skin. Says Sibilia: "Now that we know about this mechanism, treatments in the form of ointments or creams could be developed in future, which would strengthen the skin's barrier functions and thus alleviate these side effects."

More information: Lichtenberger et al. Epidermal EGFR controls cutaneous host defense and prevents inflammation, Sci Transl Med. 2013 Aug 21.

Related Stories

Mechanism for more efficient cancer treatment decoded

Jan 19, 2012

(Medical Xpress) -- A research team from the Institute for Cancer Research at the MedUni Vienna has decoded a previously unknown mechanism of the active ingredient imiquimod in tumour defence. They have been ...

New approach in the treatment of breast cancer

Aug 08, 2013

Scientists at the MedUni Vienna, in collaboration with a working group led by Nancy Hynes at the University of Basel, have discovered a new approach in the treatment of breast cancer: an international team ...

Dermatitis could be suppressed as it develops

Nov 09, 2012

Excessive immune reactions against the body's own skin cells can lead to painful and even chronic dermatitis. An international team of researchers at the MedUni Vienna, the MedUni Graz and the Salk Institute ...

Recommended for you

Study pinpoints microRNA tied to colon cancer tumor growth

6 hours ago

Researchers at the University of Minnesota have identified microRNAs that may cause colon polyps from turning cancerous. The finding could help physicians provide more specialized, and earlier, treatment before colon cancer ...

Obesity tied to higher cancer risk for CRC survivors

8 hours ago

(HealthDay)—Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer, according to research published ...

User comments